Tony Natale

Bio

A member of Prism's life sciences investment team, Tony blends his extensive business, investment and company formation experience with a background in clinical medicine. He focuses on medical device investments for the firm. He is currently a director for Avedro, XLumena and Entrigue Surgical. Previously he was a director and lead investor of several venture-backed life sciences companies, including Mako Surgical. Prior to joining Prism in 2006, Tony was a Venture Partner with MDS Capital. There, he made and managed investments in the medical technology sector, focusing on a range of device and diagnostic companies. He built the firm’s presence in the U.S. Medtech venture community and led all investment activities for MDS’ U.S. early stage fund, playing a founding investor role in multiple companies, and substantially growing the firm’s seed-stage presence and capabilities. Tony has invested across a number of therapeutic areas, including orthopedics, interventional medicine, radiation oncology, minimally invasive technologies, neurology, robotics and women’s health. He has extensive knowledge in company formation, deal structuring and syndication. A committed board member, Tony works alongside entrepreneurs to build out management teams, establish effective corporate governance and bring operational discipline to R&D and early commercialization efforts. Tony’s clinical background is surgical. He trained in General Surgery and Otolaryngology/Head and Neck Surgery at the University of Connecticut and Hartford Hospital and held clinical appointments in Hartford area hospitals before transitioning into entrepreneurial activities. He holds a B.A., Phi Beta Kappa, from the University of Virginia, an M.D. from the University of Florida College of Medicine and an M.B.A. with a concentration in Finance from Yale University’s School of Management.